Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGi change
Goodnick, P.J.; Fieve, R.R.; Peselow, E.D.; Barouche, F.; Schlegel, A.
Psychopharmacology Bulletin 23(1): 162-163
1987
ISSN/ISBN: 0048-5764 PMID: 3496624 Document Number: 290199
Document emailed within 1 workday
Related Documents
Bennie, E.H.; Mullin, J.M.; Martindale, J.J. 1995: A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression Journal of Clinical Psychiatry 56(6): 229-237Beasley, C.M.; Nilsson, M.E.; Koke, S.C.; Gonzales, J.S. 2000: Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose Journal of Clinical Psychiatry 61(10): 722-728
Feighner, J.; Targum, S.D.; Bennett, M.E.; Roberts, D.L.; Kensler, T.T.; D'Amico, M.F.; Hardy, S.A. 1998: A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression Journal of Clinical Psychiatry 59(5): 246-253
McGrath, P.J.; Stewart, J.W.; Petkova, E.; Quitkin, F.M.; Amsterdam, J.D.; Fawcett, J.; Reimherr, F.W.; Rosenbaum, J.F.; Beasley, C.M. 2000: Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression Journal of Clinical Psychiatry 61(7): 518-524
Dunner, D.L.; Cohn, J.B.; Walshe, T.; Cohn, C.K.; Feighner, J.P.; Fieve, R.R.; Halikas, J.P.; Hartford, J.T.; Hearst, E.D.; Settle, E.C. 1992: Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression Journal of Clinical Psychiatry 53 Suppl: 57-60
Reimherr, F.W.; Chouinard, G.; Cohn, C.K.; Cole, J.O.; Itil, T.M.; LaPierre, Y.D.; Masco, H.L.; Mendels, J. 1990: Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression Journal of Clinical Psychiatry 51 Suppl B: 18-27
Maneeton, N.; Thongkam, A.; Maneeton, B. 2010: Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study Journal of the Medical Association of Thailand 93(3): 337-342
Levine, S.; Anderson, D.; Bystritsky, A.; Baron, D. 1990: A report of eight HIV-seropositive patients with major depression responding to fluoxetine Journal of Acquired Immune Deficiency Syndromes 3(11): 1074-1077
Turpie, A.G.G.; Bauer, K.A.; Eriksson, B.I.; Lassen, M.R. 2002: Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies Archives of Internal Medicine 162(16): 1833-1840
Dalery, J.; Bouhassira, M.; Kress, J.P.; Lancrenon, S.; Tafani, A.; Hantouche, E.G. 1995: Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine L'Encephale 21(3): 217-225
Rahman, M.K.; Akhtar, M.J.; Savla, N.C.; Sharma, R.R.; Kellett, J.M.; Ashford, J.J. 1991: A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients British Journal of Clinical Practice 45(4): 255-258
Cornelius, J.R.; Salloum, I.M.; Cornelius, M.D.; Perel, J.M.; Ehler, J.G.; Jarrett, P.J.; Levin, R.L.; Black, A.; Mann, J.J. 1995: Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics Psychopharmacology Bulletin 31(2): 297-303
Kreider, M.S.; Bushnell, W.D.; Oakes, R.; Wheadon, D.E. 1995: A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period Journal of Clinical Psychiatry 56(4): 142-145
Bruynooghe, F.; Geerts, S.; van Maele, G.; Vögtle-Junkert, U. 1992: Treatment of reactive depression with sulpiride. Double-blind study with sulpiride and amitriptyline in an interindividual comparison Fortschritte der Medizin 110(27): 498-502
Holmskov, A.; Schroder, P. 1975: Diazepam in obstetrics. a double-blind study on duration of labor, pain, Apgar score and complications Ugeskrift for Laeger 137(13): 734-737
Dominguez, R.A.; Kumar, A.M.; Cua, W. 1996: Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine Journal of Clinical Psychopharmacology 16(4): 320-323
Mulsant, B.H.; Sweet, R.A.; Rosen, J.; Pollock, B.G.; Zubenko, G.S.; Flynn, T.; Begley, A.E.; Mazumdar, S.; Reynolds, C.F. 2001: A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life Journal of Clinical Psychiatry 62(8): 597-604
Kiev, A. 1974: Double-blind comparison of thiothixene and protriptyline in psychotic depression Advances in Biochemical Psychopharmacology 9: 511-517
Thase, M.E.; Blomgren, S.L.; Birkett, M.A.; Apter, J.T.; Tepner, R.G. 1997: Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline Journal of Clinical Psychiatry 58(1): 16-21
Sheikha, S.H.; Wagner, K.D.; Wagner, R.F. 1993: Fluoxetine treatment of trichotillomania and depression in a prepubertal child Cutis 51(1): 50-52